Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2R | P25116 | 2/20 | 0.48 |
| ▸ | GRB2 | P62993 | 1/20 | 0.46 |
| ▸ | NMUR2 | Q9GZQ4 | 5/20 | 0.44 |
| ▸ | APLNR | P35414 | 1/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 3/20 | 0.44 |
| ▸ | NTSR2 | O95665 | 2/20 | 0.44 |
| ▸ | NMUR1 | Q9HB89 | 4/20 | 0.43 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.43 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | NRP1 | O14786 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29364295 | 0.91 | BDKRB2 (0.48) | F2RGRB2NTSR1BDKRB2F2 | |
| SCHEMBL29566135 | 0.90 | F2 (0.55) | F2RGRB2NMUR2APLNRNTSR1 | |
| SCHEMBL30525426 | 0.87 | EPHA2 (0.51) | — | |
| SCHEMBL29582550 | 0.86 | BDKRB2 (0.48) | F2RNMUR2APLNRNTSR1BDKRB2 | |
| SCHEMBL29457591 | 0.84 | F2R (0.48) | F2RGRB2NMUR2NTSR1NMUR1 | |
| SCHEMBL29574154 | 0.83 | F2 (0.49) | GRB2CAPN1F2 | |
| SCHEMBL29364214 | 0.82 | KEAP1 (0.46) | GRB2NTSR1NTSR2CAPN1F2 | |
| SCHEMBL29462901 | 0.82 | KEAP1 (0.46) | GRB2NTSR1NTSR2CAPN1F2 | |
| SCHEMBL29839268 | 0.80 | REN (0.47) | F2RF2 | |
| SCHEMBL30272500 | 0.80 | REN (0.45) | F2RCAPN1F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11718687-B2 | Biomoletron for regulation stem cell differentiation | SOGANGN UNIVERSITY RESEARCH FOUNDATION (KR) | 2023-08-08 | — | — | US | claimed |
| EP-4680727-A2 | METHODS FOR IN VIVO EDITING OF B CELLS | Walking Fish Therapeutics, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| EP-4602151-A1 | NOVEL CELL LINES AND THEIR USE IN THERAPY | The University of York (GB) | 2025-08-20 | — | — | EP | disclosed |
| WO-2024196669-A2 | METHODS FOR IN VIVO EDITING OF B CELLS | WALKING FISH THERAPEUTICS, INC. (US) | 2024-09-26 | — | — | WO | disclosed |
| WO-2024079477-A1 | NOVEL CELL LINES AND THEIR USE IN THERAPY | THE UNIVERSITY OF YORK (GB) | 2024-04-18 | — | — | WO | disclosed |
| US-20240094211-A1 | COMPOSITIONS AND METHODS TARGETING S100A10 FOR THE TREATMENT AND DIAGNOSIS OF LIVER CANCER | THE UNIVERSITY OF HONG KONG (CN) | 2024-03-21 | — | — | US | disclosed |
| US-20240051997-A1 | SAP AND PEPTIDOMIMETIC COMPOSITIONS FOR REDUCING SYMPTOMS OF INFLAMMATION | VIVEX BIOLOGICS GROUP, INC. | 2024-02-15 | — | — | US | disclosed |
| EP-3611183-B1 | EPITOPE PEPTIDE SPECIFICALLY RECOGNIZING AUTOANTIBODY AGAINST AQUAPORIN 5, AND USE THEREOF | SEOUL NAT UNIV R&DB FOUNDATION (KR) | 2023-12-27 | — | — | EP | disclosed |
| US-20230348534-A1 | SAP AND PEPTIDOMIMETICS FOR TREATMENT OF EYE DISEASE | VIVEX BIOLOGICS GROUP, INC. | 2023-11-02 | — | — | US | disclosed |
| WO-2023191209-A1 | MICELLE INCLUDING HYDROPHILIC PEPTIDE AND USE THEREOF | 주식회사 퓨전바이오텍 | 2023-10-05 | — | — | WO | disclosed |
| EP-3768296-B1 | SAP AND PEPTIDOMIMETICS FOR TREATMENT OF EYE DISEASE | ARCH BIOSURGERY INC (US) | 2023-09-06 | — | — | EP | disclosed |
| US-11718687-B2 | Biomoletron for regulation stem cell differentiation | SOGANGN UNIVERSITY RESEARCH FOUNDATION (KR) | 2023-08-08 | — | — | US | disclosed |
| CN-115970059-A | Compositions comprising elastin-like polypeptides and acellular dermal matrix and uses thereof | 上海瑄元生物科技有限公司 | 2023-04-18 | — | — | CN | disclosed |